Abu Dhabi’s Mubadala and G42 to merge healthcare units for futuristic medical research – The National

Abu Dhabi’s Mubadala and G42 to merge healthcare units for futuristic medical research – The National

Abu Dhabi sovereign wealth fund Mubadala and artificial intelligence company G42 will merge their healthcare units to form a company that will focus on using future technology to revolutionise the industry across the region.

The combined entity, which aims to operate at the forefront of medical research and innovation, is intended to become a vertically integrated healthcare business by delivering pioneering clinical solutions to help solve global critical health and diagnostic challenges, the companies said on Thursday.

Hasan Al Nowais, chief executive of Mubadala Health, has been appointed to lead the new entity in the same role.